Top

Cancer Chemotherapy and Pharmacology

Published in:

01-05-1999 | Article

Successful management of microscopic residual disease in large bowel cancer

Author: Paul H. Sugarbaker

Published in: Cancer Chemotherapy and Pharmacology | Special Issue 1/1999

Title: Successful management of microscopic residual disease in large bowel cancer
Author: Paul H. Sugarbaker
Publication date: 01-05-1999
Publisher: Springer-Verlag
Published in: Cancer Chemotherapy and Pharmacology / Issue Special Issue 1/1999
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI: https://doi.org/10.1007/s002800051093

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Special Issue 1/1999

In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors

Critical determinants of cancer metastasis: rationale for therapy

Regulatory issues in the evaluation of antimetastatic and other novel anticancer therapies

Preface

Involvement of VEGF and its receptors in ascites tumor formation

Biological implications of macrophage infiltration in human tumor angiogenesis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer